A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

1. Bartlett, N.L.
2. Herrera, A.F.
3. Domingo-Domenech, E.
4. Mehta, A.
5. Forero-Torres, A.
6. Garcia-Sanz, R.
7. Armand, P.
8. Devata, S.
9. Izquierdo, A.R.
10. Lossos, I.S.
11. Reeder, C.
12. Sher, T.
13. Chen, R.
14. Schwarz, S.E.
15. Alland, L.
16. Strassz, A.
17. Prier, K.
18. Choe-Juliak, C.
19. Ansell, S.M.